In a recent episode of Onc Now, Stephen Chan, Clinical Professor of Clinical Oncology at The Chinese University of Hong Kong, examines key advancements in hepatobiliary and pancreatic cancers. He highlights innovations in translational science, precision therapies, and the urgent need for improved care for neuroendocrine tumors. Chan emphasizes his collaboration with the Hand-in-Hand Cancer Foundation, which focuses on holistic support and education for patients and families.
He notes a concerning rise in pancreatic cancer cases post COVID-19, stressing both the progress made in oncology and the breakthroughs still necessary. Chan’s experience spans two decades, from leading clinical trials to researching effective management strategies for various cancers, underscoring the importance of integrating compassionate care into medical treatment.